Wnt/β-catenin signaling in cancers and targeted therapies
F Yu, C Yu, F Li, Y Zuo, Y Wang, L Yao, C Wu… - … and Targeted Therapy, 2021 - nature.com
Wnt/β-catenin signaling has been broadly implicated in human cancers and experimental
cancer models of animals. Aberrant activation of Wnt/β-catenin signaling is tightly linked with …
cancer models of animals. Aberrant activation of Wnt/β-catenin signaling is tightly linked with …
Targeting the Wnt/β-catenin signaling pathway in cancer
Y Zhang, X Wang - Journal of hematology & oncology, 2020 - Springer
The aberrant Wnt/β-catenin signaling pathway facilitates cancer stem cell renewal, cell
proliferation and differentiation, thus exerting crucial roles in tumorigenesis and therapy …
proliferation and differentiation, thus exerting crucial roles in tumorigenesis and therapy …
Tumor cell plasticity in targeted therapy-induced resistance: mechanisms and new strategies
ZD Shi, K Pang, ZX Wu, Y Dong, L Hao… - … and Targeted Therapy, 2023 - nature.com
Despite the success of targeted therapies in cancer treatment, therapy-induced resistance
remains a major obstacle to a complete cure. Tumor cells evade treatments and relapse via …
remains a major obstacle to a complete cure. Tumor cells evade treatments and relapse via …
Anti-inflammatory drugs as anticancer agents
S Zappavigna, AM Cossu, A Grimaldi… - International journal of …, 2020 - mdpi.com
Inflammation is strictly associated with cancer and plays a key role in tumor development
and progression. Several epidemiological studies have demonstrated that inflammation can …
and progression. Several epidemiological studies have demonstrated that inflammation can …
Cancer-associated fibroblasts: the chief architect in the tumor microenvironment
Stromal heterogeneity of tumor microenvironment (TME) plays a crucial role in malignancy
and therapeutic resistance. Cancer-associated fibroblasts (CAFs) are one of the major …
and therapeutic resistance. Cancer-associated fibroblasts (CAFs) are one of the major …
Emerging roles of Wnt ligands in human colorectal cancer
X Nie, H Liu, L Liu, YD Wang, WD Chen - Frontiers in oncology, 2020 - frontiersin.org
Colorectal cancer (CRC) is the fourth leading cause of cancer death worldwide, and
constitutive activation of the Wnt signaling pathway is universal in most CRC cases. Wnt …
constitutive activation of the Wnt signaling pathway is universal in most CRC cases. Wnt …
Blocking the Wnt/β-catenin signaling pathway to treat colorectal cancer: Strategies to improve current therapies
Y Chen, M Chen, K Deng - International journal of …, 2022 - spandidos-publications.com
Colorectal cancer (CRC) is one of the most common malignant tumor types occurring in the
digestive system. The incidence of CRC has exhibits yearly increases and the mortality rate …
digestive system. The incidence of CRC has exhibits yearly increases and the mortality rate …
Crosstalk between CAFs and tumour cells in head and neck cancer
X Li, C González-Maroto, M Tavassoli - Cell Death Discovery, 2024 - nature.com
Head and neck squamous cell carcinomas (HNSCCs) are amongst the most aggressive,
complex, and heterogeneous malignancies. The standard of care treatments for HNC …
complex, and heterogeneous malignancies. The standard of care treatments for HNC …
Molecular mechanisms of epithelial to mesenchymal transition in tumor metastasis
A Nieszporek, K Skrzypek, G Adamek… - Acta Biochimica …, 2019 - ruj.uj.edu.pl
Epithelial to mesenchymal transition (EMT) is a process where cancer cells lose their
epithelial features, the cytoskeletal architecture is re-organized, the cell shape changes and …
epithelial features, the cytoskeletal architecture is re-organized, the cell shape changes and …
Cancer stem cells in head and neck squamous cell carcinoma: identification, characterization and clinical implications
C Peitzsch, J Nathansen, SI Schniewind, F Schwarz… - Cancers, 2019 - mdpi.com
Head and neck squamous cell carcinoma (HNSCC) is the sixth most commonly diagnosed
cancer worldwide. Despite advances in the treatment management, locally advanced …
cancer worldwide. Despite advances in the treatment management, locally advanced …